Related references
Note: Only part of the references are listed.Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn's Disease
Marta S. Alexdottir et al.
FRONTIERS IN MEDICINE (2022)
Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression
Junlin Zhang et al.
NUTRIENTS (2022)
Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms
Mengfei Fu et al.
FRONTIERS IN NUTRITION (2022)
B-cell activating factor (BAFF) expression is associated with Crohn's disease and can serve as a potential prognostic indicator of disease response to Infliximab treatment
Nikolaos-Panagiotis Andreou et al.
DIGESTIVE AND LIVER DISEASE (2021)
Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease
Rebecka Ventin-Holmberg et al.
JOURNAL OF CROHNS & COLITIS (2021)
Prognostic nutritional index and the risk of mortality in patients with hypertrophic cardiomyopathy
Ziqiong Wang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2021)
A random forest model predicts responses to infliximab in Crohn's disease based on clinical and serological parameters
Yong Li et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn's Disease
Li Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapies
Iris Dotan et al.
MEDICINAL RESEARCH REVIEWS (2020)
Prognostic nutritional index predicts one-year outcome in heart failure with preserved ejection fraction
Hicaz Zencirkiran Agus et al.
ACTA CARDIOLOGICA (2020)
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
Nutritional Aspects in Inflammatory Bowel Diseases
Paola Balestrieri et al.
NUTRIENTS (2020)
Serological Biomarkers of Tissue Turnover Identify Responders to Anti-TNF Therapy in Crohn's Disease: A Pilot Study
Wouter T. van Haaften et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2020)
Are We Ready to Include Prognostic Factors in Inflammatory Bowel Disease Trials?
Christopher R. Lindholm et al.
CURRENT PHARMACEUTICAL DESIGN (2019)
Clinical significance of prognostic nutritional index (PNI) in malignant melanoma
Cem Mirili et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Mucosal IL13RA2 expression predicts nonresponse to anti-TNF therapy in Crohn's disease
Bram Verstockt et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin
Zhen Zhou et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease
Amy Hemperly et al.
CLINICAL PHARMACOKINETICS (2018)
Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
Youlian Zhou et al.
MSYSTEMS (2018)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease
Johannan F. Brandse et al.
INFLAMMATORY BOWEL DISEASES (2017)
Randomised clinical trial: deep remission in biologic and immunomodulator naive patients with Crohn's disease - a SONIC post hoc analysis
J. -F. Colombel et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis
Mahmoud H. Mosli et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
A Matrix-based Model Predicts Primary Response to Infliximab in Crohn's Disease
Thomas Billiet et al.
JOURNAL OF CROHNS & COLITIS (2015)
Impact of disease location on fecal calprotectin levels in Crohn's disease
Krisztina B. Gecse et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2015)
Disease monitoring in inflammatory bowel disease
Shannon Chang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Patient Factors That Increase Infliximab Clearance and Shorten Half-life in Inflammatory Bowel Disease: A Population Pharmacokinetic Study
Iris Dotan et al.
INFLAMMATORY BOWEL DISEASES (2014)
High C-reactive protein in Crohn's disease patients predicts nonresponse to infliximab treatment
Fernando Magro et al.
JOURNAL OF CROHNS & COLITIS (2014)
C-reactive protein is an indicator of serum infliximab level in predicting loss of response in patients with Crohn's disease
Toshifumi Hibi et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis
Kavinderjit S. Nanda et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Subgroup analysis of the placebo-controlled CHARM trial: Increased remission rates through 3 years for adalimumab-treated patients with early Crohn's disease
S. Schreiber et al.
JOURNAL OF CROHNS & COLITIS (2013)
Nutritional management of Crohn's disease
Clare F. Donnellan et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2013)
A Prospective Study of Cigarette Smoking and the Risk of Inflammatory Bowel Disease in Women
Leslie M. Higuchi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study
D. Laharie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Review article: loss of response to anti-TNF treatments in Crohn's disease
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The Utility of Biomarkers in the Diagnosis and Therapy of Inflammatory Bowel Disease
James D. Lewis
GASTROENTEROLOGY (2011)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Risk Factors Associated With Progression to Intestinal Complications of Crohn's Disease in a Population-Based Cohort
Kelvin T. Thia et al.
GASTROENTEROLOGY (2010)
Current Directions in IBD Therapy: What Goals Are Feasible With Biological Modifiers?
William J. Sandborn
GASTROENTEROLOGY (2008)
Lymphocyte homing and its role in the pathogenesis of IBD
Bertus Eksteen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Nationwide prevalence and prognostic significance of clinically diagnosable protein-calorie malnutrition in hospitalized inflammatory bowel disease patients
Geoffrey C. Nguyen et al.
INFLAMMATORY BOWEL DISEASES (2008)
Smoking and inflammatory bowel disease: A meta-analysis
Suhal S. Mahid et al.
MAYO CLINIC PROCEEDINGS (2006)
Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease
Elana A. Maser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Risk factors regarding the need for a second operation in patients with Crohn's disease
B Avidan et al.
DIGESTION (2005)
C-reactive protein as a marker for inflammatory bowel disease
S Vermeire et al.
INFLAMMATORY BOWEL DISEASES (2004)
Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity
F Stam et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
T ten Hove et al.
GUT (2002)
Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans
TM Tumpey et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
